Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
doi: 10.1016/j.jhepr.2019.07.002 138 PatelVJoharapurkarAKshirsagarSSutariyaBPatelMPatelHet al
Get strong credentials and flat pricing but IVY RX GLP-1 Review: Great Care, Shaky Claims in 2026 I ordered GLP-1s from IVY RX, reviewed the service firsthand, and scored it 71/100
In short, whether or not someone can access a GLP-1 medication generally depends on your insurance plan
Weight alone isn't enough